On the recordFebruary 25, 2014
It is certainly fair for the program to expect that if the plans are securing discounts, that some of that benefit would come back to the program and to the taxpayers.
Source
congress.govEditor's note · Context
Sarbanes emphasizes the importance of passing savings from drug discounts back to taxpayers.
Share
More from John Sarbanes
Apr 25, 2023
As the Inflation Reduction Act reforms continue to be implemented over the coming years, we must continue to build on this success.
Oct 17, 2023
This bill takes important steps to support the ongoing restoration of the Chesapeake Bay by reauthorizing NOAA's Chesapeake Bay Office and authorizing the agency's long-running Bay Watershed Education and Training, or B-WET Grant program.
Apr 25, 2023
Last year, as you know, Congress finally--finally, after many, many decades, really--took the historic step of standing up to Big Pharma and enacting policies that are already--we are seeing it--lowering healthcare costs for millions of…
Other voices in this conversation
